Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer.

A prospective biomarker trial found that longitudinal plasma circulating tumor HPV DNA during surveillance detected clinical recurrence in nonmetastatic HPV-associated oropharyngeal cancer.

Journal of Clinical OncologyPubMed 32017652DOI 10.1200/JCO.19.02444